Search research articles
Contact Us
Filters
Showing results (351-360 of 607) with videos related to
Page
of 61
Sort By:
Cells
|
April 26, 2024
Exploring Anti-Fibrotic Effects of Adipose-Derived Stem Cells: Transcriptome Analysis upon Fibrotic, Inflammatory, and Hypoxic Conditioning
Marvin L Frommer, Benjamin J Langridge, Alexandra Beedie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 31, 2025
Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis
Stefano Di Donato, Rebecca Ross, Ranjitha Karanth, et al.
Heart (British Cardiac Society)
|
December 13, 2005
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
M H Williams, C Das, C E Handler, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
July 15, 2024
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis
Elizabeth R Volkmann, Christopher P Denton, Martin Kolb, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 1, 2021
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial
Dinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
Current Medical Research and Opinion
|
July 23, 2019
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Marlies Wijsenbeek, Michael Kreuter, Amy Olson, et al.
Arthritis and Rheumatism
|
December 1, 2007
Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts
Xu Shi-wen, Laura Kennedy, Elisabetta A Renzoni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 7, 2018
Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2
Justin Gillespie, Rebecca L Ross, Clarissa Corinaldesi, et al.
Cells
|
February 15, 2022
Induction of Pro-Fibrotic CLIC4 in Dermal Fibroblasts by TGF-β/Wnt3a Is Mediated by GLI2 Upregulation
Christopher W Wasson, Begoña Caballero-Ruiz, Justin Gillespie, et al.
Annals of the Rheumatic Diseases
|
September 10, 2013
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors
Britta Maurer, Alfiya Distler, Clara Dees, et al.
Page
of 61
Search research articles
Search
Showing results (351-360 of 607) with videos related to
Sort By:
Page
of 61
Cells
|
April 26, 2024
Exploring Anti-Fibrotic Effects of Adipose-Derived Stem Cells: Transcriptome Analysis upon Fibrotic, Inflammatory, and Hypoxic Conditioning
Marvin L Frommer, Benjamin J Langridge, Alexandra Beedie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 31, 2025
Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis
Stefano Di Donato, Rebecca Ross, Ranjitha Karanth, et al.
Heart (British Cardiac Society)
|
December 13, 2005
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
M H Williams, C Das, C E Handler, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
July 15, 2024
Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis
Elizabeth R Volkmann, Christopher P Denton, Martin Kolb, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 1, 2021
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial
Dinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
Current Medical Research and Opinion
|
July 23, 2019
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Marlies Wijsenbeek, Michael Kreuter, Amy Olson, et al.
Arthritis and Rheumatism
|
December 1, 2007
Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts
Xu Shi-wen, Laura Kennedy, Elisabetta A Renzoni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 7, 2018
Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2
Justin Gillespie, Rebecca L Ross, Clarissa Corinaldesi, et al.
Cells
|
February 15, 2022
Induction of Pro-Fibrotic CLIC4 in Dermal Fibroblasts by TGF-β/Wnt3a Is Mediated by GLI2 Upregulation
Christopher W Wasson, Begoña Caballero-Ruiz, Justin Gillespie, et al.
Annals of the Rheumatic Diseases
|
September 10, 2013
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors
Britta Maurer, Alfiya Distler, Clara Dees, et al.
Page
of 61